Evidence map›Paper›PMID 35283767›Full record

ArticleFrontiers in physiology2022

Victoria L Messerschmidt, Uday Chintapula, Fabrizio Bonetesta, Samantha Laboy-Segarra, Amir Naderi, Kytai T Nguyen, Hung Cao, Edward Mager, Juhyun Lee

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Immunomodulation in age-related disorders and nanotechnology interventions.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Victoria L MesserschmidtDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Uday ChintapulaDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Fabrizio BonetestaDepartment of Biological Sciences, University of North Texas, Denton, TX, United States.
Samantha Laboy-SegarraDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Amir NaderiDepartment of Electrical Engineering and Computer Science, University of California, Irvine, Irvine, CA, United States.
Kytai T NguyenDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Hung CaoDepartment of Electrical Engineering and Computer Science, University of California, Irvine, Irvine, CA, United States.
Edward MagerDepartment of Biological Sciences, University of North Texas, Denton, TX, United States.
Juhyun LeeDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
The University of Texas Southwestern Medical Center · USUniversity of California, Irvine · USUniversity of North Texas · USThe University of Texas at Arlington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the era of the advanced nanomaterials, use of nanoparticles has been highlighted in biomedical research. However, the demonstration of DNA plasmid delivery with nanoparticles for

Indexed as

gene deliverynon-viral transfectionNotch signalingPLGA nanoparticlestoxicityzebrafish

Identifiers

PMID35283767
PMCPMC8906778
OpenAlexW4212971734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.